|
Novel Biomarker for Diagnosis and Treatment of Chronic Lung Diseases
This invention is a targeted method of treating conditions associated with aberrant L1 expression, including cancers. The method involves determining the expression levels of L1 in a patient and then administering a known TGF-β1 inhibitor. Further, the invention acts on the discovery of an underlying mechanism of aberrant L1 expression that will...
Published: 11/16/2023
|
Inventor(s): Kenneth Ramos, Elsa Reyes Reyes, Pasano Bojang, Patrick Silva
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Therapeutics
|
